Monte Rosa Therapeutics, Inc.
GLUE- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001826457
In the last 90 days, Monte Rosa Therapeutics, Inc. insiders filed 0 open-market purchases and 3 sales; 192 institutions reported holding it in 13F filings for Q2 2026, worth $2.24B in total; Duquesne Family Office is the only superinvestor holding it.
13F holders, Q3 2025
Institutional positions in Monte Rosa Therapeutics, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 129
- +13 vs. Q2 2025
- Shares held
- 60.0M
- −2.17M (−3.5%) vs. Q2 2025
- Total value
- $444.9M
- +$164.3M (+58.6%) vs. Q2 2025
- New holders
- 27
- 35 more added
- Sold out
- 14
- 41 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GLUE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 192 | $2.24B |
| Q1 2026 | 191 | $1.43B |
| Q4 2025 | 161 | $1.01B |
| Q3 2025 | 129 | $444.9M |
| Q2 2025 | 116 | $280.6M |
| Q1 2025 | 106 | $276.2M |
| Q4 2024 | 105 | $423.3M |
| Q3 2024 | 81 | $263.7M |
| Q2 2024 | 75 | $171.7M |
| Q1 2024 | 68 | $281.3M |
| Q4 2023 | 71 | $226.6M |
| Q3 2023 | 71 | $201.4M |
| Q2 2023 | 68 | $272.3M |
| Q1 2023 | 69 | $309.8M |
| Q4 2022 | 66 | $313.8M |
| Q3 2022 | 70 | $328.8M |
| Q2 2022 | 57 | $375.0M |
| Q1 2022 | 52 | $559.9M |
| Q4 2021 | 53 | $742.0M |
| Q3 2021 | 56 | $759.4M |
| Q2 2021 | 48 | $705.1M |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Monte Rosa Therapeutics, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Russell Investments Group, Ltd. | 4,318 | $32.0K | 0.00% | +4,318 | New |
| Legal & General Group Plc | 4,245 | $31.5K | 0.00% | 00.0% | Unchanged |
| Ameritas Investment Partners, Inc. | 4,184 | $31.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 3,443 | $25.5K | 0.00% | −1,549−31.0% | Reduced |
| Sterling Capital Management LLC | 3,218 | $23.8K | 0.00% | +2,051+175.7% | Added |
| California State Teachers Retirement System | 3,051 | $22.6K | 0.00% | +2+0.1% | Added |
| EverSource Wealth Advisors, LLC | 2,987 | $22.1K | 0.00% | −287−8.8% | Reduced |
| Nisa Investment Advisors, LLC | 2,700 | $20.0K | 0.00% | −48−1.7% | Reduced |
| Mirae Asset Global Investments Co., Ltd. | 2,388 | $17.7K | 0.00% | +12+0.5% | Added |
| Advisor Group Holdings, Inc. | 2,485 | $15.3K | 0.00% | +201+8.8% | Added |
| Citigroup Inc | 1,774 | $13.1K | 0.00% | −21,139−92.3% | Reduced |
| Amalgamated Bank | 1,425 | $11.0K | 0.00% | 00.0% | Unchanged |
| GF Fund Management Co. Ltd. | 1,317 | $9.76K | 0.00% | −255−16.2% | Reduced |
| IFP Advisors, Inc | 1,152 | $8.54K | 0.00% | −30−2.5% | Reduced |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 1,054 | $7.81K | 0.00% | −506−32.4% | Reduced |
| Comerica Bank | 841 | $6.23K | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 598 | $4.43K | 0.00% | +116+24.1% | Added |
| Point72 Europe (London) LLP | 591 | $4.38K | 0.00% | +591 | New |
| Optiver Holding B.V. | 584 | $4.33K | 0.00% | +584 | New |
| The PNC Financial Services Group, Inc. | 457 | $3.39K | 0.00% | +340+290.6% | Added |
| SBI Securities Co., Ltd. | 318 | $2.36K | 0.00% | +48+17.8% | Added |
| Daiwa Securities Group Inc. | 203 | $2.00K | 0.00% | 00.0% | Unchanged |
| Larson Financial Group LLC | 181 | $1.34K | 0.00% | 00.0% | Unchanged |
| True Wealth Design, LLC | 84 | $623 | 0.00% | +42+100.0% | Added |
| Rothschild Investment LLC | 50 | $371 | 0.00% | −55−52.4% | Reduced |
| Clearstead Advisors, LLC | 35 | $260 | 0.00% | +10+40.0% | Added |
| Turning Point Benefit Group, Inc. | 14 | $105 | 0.00% | +14 | New |
| Bessemer Group Inc | 34 | $0 | 0.00% | +34 | New |
| Summit Wealth Group LLC | 2,002 | – | – | +2,002 | New |
| Avoro Capital Advisors LLC | 0 | $0 | 0.00% | −3,725,000−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −109,227−100.0% | Sold out |
| Hillsdale Investment Management Inc. | 0 | $0 | 0.00% | −60,100−100.0% | Sold out |
| Integrated Quantitative Investments LLC | 0 | $0 | 0.00% | −35,400−100.0% | Sold out |
| Stonepine Capital Management, LLC | 0 | $0 | 0.00% | −30,000−100.0% | Sold out |
| UBS Asset Management Americas Inc | 0 | $0 | 0.00% | −24,100−100.0% | Sold out |
| Sherbrooke Park Advisers LLC | 0 | $0 | 0.00% | −21,867−100.0% | Sold out |
| Voya Investment Management LLC | 0 | $0 | 0.00% | −12,958−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −10,857−100.0% | Sold out |
| Brighton Jones LLC | 0 | $0 | 0.00% | −10,559−100.0% | Sold out |
| Raymond James Financial Inc | 0 | $0 | 0.00% | −1,200−100.0% | Sold out |
| Caitong International Asset Management Co., Ltd | 0 | $0 | 0.00% | −1,066−100.0% | Sold out |
| Skopos Labs, Inc. | 0 | $0 | 0.00% | −92−100.0% | Sold out |
| GAMMA Investing LLC | 0 | $0 | 0.00% | −80−100.0% | Sold out |